Quantcast

Latest congenital heart disease Stories

2014-09-16 12:24:58

Peer-reviewed case report says implantation of the SynCardia Total Artificial Heart restores "normal biventricular circulation" to a congenital patient with only one functioning ventricle. The male patient was bridged to a donor heart 61 days later. TUCSON, Ariz., Sept. 16, 2014 /PRNewswire/ -- Surgeons at The Children's Hospital of Philadelphia describe in a case report the first successful use of a SynCardia temporary Total Artificial Heart (TAH-t) in a 13- year-old boy with failing Fontan...

2014-09-15 08:28:40

DUBLIN, Sept. 15, 2014 /PRNewswire/ -- Research and Markets has announced the addition of the "Global Heart Defect Closure Devices Market 2014-2018" report to their offering. http://photos.prnewswire.com/prnvar/20130307/600769 Heart defect closure devices are used for the treatment of several CHDs. The heart closure devices help when closing the ostium/ hole/ deficiency in the structure of the heart present in the septal walls or blood vessels that occurs in the patients with CHDs. CHD is an...

2014-08-25 16:23:51

LONDON, Aug. 25, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:Atrial Septal Defect Global Clinical Trials Review, H2, 2014https://www.reportbuyer.com/product/652978/Atrial-Septal-Defect-Global-Clinical-Trials-Review-H2-2014.htmlAtrial Septal Defect Global Clinical Trials Review, H2, 2014SummaryGlobalData's clinical trial report, "Atrial Septal Defect Global Clinical Trials Review, H2, 2014" provides data on the Atrial Septal Defect clinical trial...

2014-08-11 23:07:45

Zoloft Birth Defect Lawsuits Filed Allege SSRI Antidepressant Caused Children to Be Born with Various Congenital Malformations, Including Atrial Septal Defect; Persistent Pulmonary Hypertension of the Newborn, Neural Tube Defects, and Craniofacial Defects Reports Wright & Schulte LLC Columbus, OH (PRWEB) August 11, 2014 Wright & Schulte LLC, a nationally-recognized law firm representing plaintiffs in Zoloft lawsuits, notes that 13 new claims were recently filed in West Virginia...

2014-07-23 08:32:10

SEOUL, South Korea, July 23, 2014 /PRNewswire/ -- Mezzion Pharma Co. Ltd., announced that it has initiated a clinical program to evaluate the use of udenafil to treat adolescents who have undergone the Fontan surgical palliation for single ventricle heart defects. The clinical program will follow protocols developed by a subcommittee made up of representatives of the Pediatric Heart Network (PHN), a multi-center clinical research network funded by the National Heart, Lung, and Blood...

2014-07-09 23:03:50

NobleStitch 1 year results receive positive reviews from physicians at Congenital & Structural Interventions Congress (CSI) in Frankfurt. Fountain Valley, CA (PRWEB) July 09, 2014 Nobles Medical Technologies II (NMT2) today announced that Dr. Michael Mullen (Consultant Cardiologist at the University College Hospital and Member of the NMT2 clinical Advisory Board) presented positive results for the 1-year follow up of patients treated with NobleStitch EL PFO Closure System. NMT2...

2014-07-01 08:29:33

Adult Congenital Heart Disease Program team now among the largest in the nation HOUSTON, July 1, 2014 /PRNewswire-USNewswire/ -- Today, Texas Children's Heart Center is excited to announce the addition of two new members to its Adult Congenital Heart Disease Program team: pediatric and adult cardiologist, Dr. Peter Ermis, and pediatric and adult cardiologist, Dr. Wilson Lam. Texas Children's Heart Center is ranked #2 nationally in cardiology and heart surgery by U.S. News & World...

2014-06-25 08:30:37

This first-of-its-kind program brings together the deepest expertise to protect prenatal brain development in children with congenital heart defects PHILADELPHIA, June 25, 2014 /PRNewswire-USNewswire/ -- The Children's Hospital of Philadelphia (CHOP) today launched the Fetal Neuroprotection and Neuroplasticity Program. Building on growing evidence of the interaction of heart disease and brain development in the fetus, this Program will systematically investigate innovative therapies...

2014-06-19 23:18:18

Nobles Medical Technologies II, Inc. (NMT2) today announced that its first Swedish patient Eva has had a successful PFO closure. Fountain Valley, CA (PRWEB) June 19, 2014 Nobles Medical Technologies II, Inc. (NMT2) today announced that its first Swedish patient Eva has had a successful PFO closure. The patient, a nurse/ administrator from the hospital and rehabilitation center in Linkoping, who has suffered from stroke and migraine was being treated with aggressive medication Warfarin (a...

2014-06-10 12:29:34

TIANJIN, China, June 10, 2014 /PRNewswire/ -- On May 29, 2014, the Journey of 'Heart' summing-up meeting for the 10th anniversary of Congenital Heart Disease (CHD) screening among children in Tianjin was held in TEDA International Cardiovascular Hospital (hereinafter referred to as 'TEDA'). The benefited children and their parents, the representatives of the donating enterprises and individuals as well as the supervising officials of Tianjian municipal government and Tianjin Binhai...


Latest congenital heart disease Reference Libraries

Echocardiogram
2013-07-29 11:11:00

An echocardiogram is a test that, much like an ultrasound, uses sound waves to create a moving image of the heart. The most common type of echocardiogram is performed transthoracic, meaning the image is taken through a probe against the chest. A TTE does not involve radiation and is a very safe procedure. A cardiac sonographer will put a gel on the patient's chest and move the transducer around different areas, including directly anterior to the breastbone, inferior and lateral to the right...

More Articles (1 articles) »
Word of the Day
omadhaun
  • A fool; a simpleton: a term of abuse common in Ireland and to a less extent in the Gaelic-speaking parts of Scotland.
This word is partly Irish in origin.